JPRN-UMIN000044733Completed未知
Effect of Single Ingestion of Coffee Chlorogenic Acid on Postprandial Serum Triglyceride Levels: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study - Beneficial Effects of Coffee Chlorogenic Acid on Postprandial Serum Triglyceride Levels
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 65years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Subjects who are under physician's advice, treatment, and/or medication for dyslipidemia and/or diabetes. 2. Subjects with familial hypercholesterolemia. 3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 4. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 5. Subjects with unusually high and/or low blood pressure and/or abnormal hematological data. 6. Subjects with severe anemia. 7. Pre- or post-menopausal women complaining of obvious physical changes. 8. Subjects who experienced unpleasant feeling during drawing blood in the past. 9. Subjects who are at risk of having allergic reactions to drugs or foods especially based on coffee, milk, egg, wheat, shrimp, soybean, chicken and/or pork. 10. Subjects with lactose intolerance. 11. Subjects who regularly take medicine, functional foods, and/or supplements which would affect lipid metabolism. 12. Subjects who regularly take medicine, functional foods, and/or supplements which would affect glucose metabolism. 13. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 14. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to the screening tests. 15. Pregnant or lactating women or women who expect to be pregnant during this study. 16. Subjects who currently participate in other clinical trials, or participate within the last 4 weeks prior to the study. 17. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Investigators
Similar Trials
Completed
Not Applicable
Effect of Daily Ingestion of Coffee Chlorogenic Acid on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison StudyJPRN-UMIN000044039Hokkaido Information University72
Recruiting
Not Applicable
Coffee consumption and glucose tolerance in humans.Diabetes Mellitus type 2 (DM type II)NL-OMON23240Vrije Universiteit (VU) Amsterdam, Institute for Health Sciences. The study will be executed at the Vrije Universiteit (VU) Medical Center, Amsterdam20
Not yet recruiting
Not Applicable
Acute effects of coffee and major coffee components on glucagon-like peptide 1 response and glucose tolerance in humansimpaired glucose tolerance10018424diabetesNL-OMON31301Vrije Universiteit20
Completed
Phase 3
The effect of green coffee supplementation on patients with polycystic ovary syndromePolycystic ovary syndrom.Polycystic ovarian syndromeIRCT20180711040428N1Islamic Azad University40
Not yet recruiting
Not Applicable
Effect of green coffee extract supplementation in patients with type 2 diabetesIRCT20090203001640N18Vice Chancellor for Research of Beheshti University of Medical Sciences44